BioCentury
ARTICLE | Clinical News

AUT00063: Phase I started

June 17, 2013 7:00 AM UTC

Autifony began a placebo-controlled, U.K. Phase I trial to evaluate single and multiple ascending-doses of oral AUT00063 in about 60 healthy volunteers. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK, London...